Non-myeloablative preconditioning with ACK2 (anti-c-kit antibody) is efficient in bone marrow transplantation for murine models of mucopolysaccharidosis type II-Reference-Cited by-同舟云学术

Non-myeloablative preconditioning with ACK2 (anti-c-kit antibody) is efficient in bone marrow transplantation for murine models of mucopolysaccharidosis type II

Published:2016-11 Issue:3 Volume:119 Page:232-238
ISSN:1096-7192
Container-title:Molecular Genetics and Metabolism
language:en
Short-container-title:Molecular Genetics and Metabolism

Author:

Yokoi Takayuki,Yokoi Kentarou,Akiyama Kazumasa,Higuchi Takashi,Shimada Yohta,Kobayashi Hiroshi,Sato Taku,Ohteki Toshiaki,Otsu Makoto,Nakauchi Hiromitsu,Ida Hiroyuki,Ohashi Toya

Funder

Vehicle Racing Commemorative Foundation

Publisher

Elsevier BV

Subject

Endocrinology,Genetics,Molecular Biology,Biochemistry,Endocrinology, Diabetes and Metabolism

Reference43 articles.

1. The defect in the Hunter syndrome: deficiency of sulfoiduronate sulfatase;Bach;Proc. Natl. Acad. Sci. U. S. A.,1973

2. Recognition and diagnosis of mucopolysaccharidosis II (Hunter syndrome);Martin;Pediatrics,2008

3. A phase II/III clinical study of enzyme replacement therapy with idursulfase in mucopolysaccharidosis II (Hunter syndrome);Muenzer;Genet. Med.,2006

4. Japan elaprase treatment (JET) study: idursulfase enzyme replacement therapy in adult patients with attenuated Hunter syndrome (Mucopolysaccharidosis II, MPS II);Okuyama;Mol. Genet. Metab,2010

5. Long-term, open-labeled extension study of idursulfase in the treatment of Hunter syndrome;Muenzer;Genet. Med,2011

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting the central nervous system in lysosomal storage diseases: Strategies to deliver therapeutics across the blood-brain barrier;Molecular Therapy;2023-03

2. Effective therapies for sickle cell disease: are we there yet?;Trends in Genetics;2022-12

3. Hematopoietic cell transplantation for sickle cell disease: updates and future directions;Hematology;2021-12-10

4. Sirolimus augments hematopoietic stem and progenitor cell regeneration following hematopoietic insults;Stem Cells;2020-12-12

5. Efficient engraftment of genetically modified cells is necessary to ameliorate central nervous system involvement of murine model of mucopolysaccharidosis type II by hematopoietic stem cell targeted gene therapy;Molecular Genetics and Metabolism;2020-08